-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Valacyclovir-[d4] Hydrochloride
Category | Herpes simplex Virus (HSV) |
CAS | 1331910-75-8 |
Description | Valacyclovir-[d4] Hydrochloride is the labelled analogue of Valacyclovir Hydrochloride, which is a derivative of valacyclovir. valacyclovir is an antiviral drug used in the management of herpes simplex, herpes zoster and herpes B. |
Product Information
Synonyms | Valacyclovir-d4 Hydrochloride; L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester-d4 monohydrochloride |
IUPAC Name | [2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-1,1,2,2-tetradeuterioethyl] (2S)-2-amino-3-methylbutanoate;hydrochloride |
Molecular Weight | 364.82 |
Molecular Formula | C13H16D4N6O4.HCl |
Canonical SMILES | CC(C)C(C(=O)OCCOCN1C=NC2=C1N=C(NC2=O)N)N.Cl |
InChI | InChI=1S/C13H20N6O4.ClH/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20;/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20);1H/t8-;/m0./s1/i3D2,4D2; |
InChIKey | ZCDDBUOENGJMLV-SRNSESIXSA-N |
Melting Point | 163-166°C |
Purity | ≥95%; ≥98% atom D |
Solubility | Slightly soluble in Methanol, Water |
Appearance | White to Pale Yellow Solid |
Storage | Store at -20°C |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
Target | HSV; Antibiotic |